BeStock  
Stocks › Biotechnology › CYTK

Cytokinetics CYTK

US equityMarket cap rank #1720Biotechnology
$50.78 −$0.68 (-1.32%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $52.48 +3.35%
Open$51.27
Prev close$51.46
Day range$50.60 – $53.45
Volume1.43M
Market cap$7.07B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-9.3x
CheapRich

Above its usual level · 65th percentile, 5-year average -10.6x

Price / book-24.3x
CheapRich

Below its usual level · 25th percentile, 5-year average -44.9x

Price / sales69.0x
CheapRich

Below its usual level · 31st percentile, 5-year average 459.8x

#4910 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-22x-16x-10x-3xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$74.49
Price vs. fair value-31.8%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB -24.34 – -44.91 25% (cheaper than usual) –
PE -9.32 -10.32 -10.58 65% (pricier than usual) –
PS 69.02 21.59 459.79 31% (cheaper than usual) #4910 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on CYTK.

Sign in to join the discussion.

Scroll to Top